Skip to Main content Skip to Navigation
Journal articles

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02465973
Contributor : Odile Filhol <>
Submitted on : Tuesday, February 4, 2020 - 11:23:04 AM
Last modification on : Thursday, July 2, 2020 - 2:56:01 PM

Links full text

Identifiers

Citation

Helena Polena, Julie Creuzet, Maeva Dufies, Adama Sidibé, Abir Khalil-Mgharbel, et al.. The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma. British Journal of Cancer, Cancer Research UK, 2018, 118 (9), pp.1179-1188. ⟨10.1038/s41416-018-0054-5⟩. ⟨hal-02465973⟩

Share

Metrics

Record views

190